| Assay ID | Title | Year | Journal | Article |
|---|
| AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID255730 | Effective p.o. dose tested for anticonvulsant activity using maximal electroshock seizure model in mouse (value range= 17.9-32.1 mg/kg) | 2005 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 15, Issue:21
| Potential metabolites of a condensed 2,3-benzodiazepine derivative. |
| AID256109 | Activity tested as behavioural change in mouse at an i.p. dose of 100 mg/kg; (loss of righting reflex) | 2005 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 15, Issue:21
| Potential metabolites of a condensed 2,3-benzodiazepine derivative. |
| AID255719 | Effective i.p. dose tested for muscle relaxant activity using inclined screen test in mouse (value range= 29.4-45.2 mg/kg) | 2005 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 15, Issue:21
| Potential metabolites of a condensed 2,3-benzodiazepine derivative. |
| AID256108 | Activity tested as behavioural change in mouse at a p.o. dose of 200 mg/kg; (loss of righting reflex) | 2005 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 15, Issue:21
| Potential metabolites of a condensed 2,3-benzodiazepine derivative. |
| AID255907 | Evaluated for inhibition of AMPA (5 uM) evoked spreading depression in isolated retina prepared from young chicken | 2005 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 15, Issue:21
| Potential metabolites of a condensed 2,3-benzodiazepine derivative. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |